Implementation of ISO 22301:2019 using ISO 31000:2018 In a Pharmaceutical Organization

– The key advantage of modern business is that it operates continuously and effectively, is constructed in accordance with legal standards, and is focused on customer needs. Pharmaceutical companies were no different. They focus on both the management system and product quality in order to conduct successful business. The implementation of ISO 22301:2018, or the “Business Continuity Management System,” will help to save the company and prevent or minimize the consequences of emergencies. To implement the project, it is necessary to assess the critical stages of the company’s activities and establish the value of each process. This information is further required for the optimal allocation of resources and building a business continuity system for a pharmaceutical company with the regulation of measures to prevent or eliminate the consequences of emergency situations as soon as possible. In this research paper, researcher want to implement ISO 22301:2019 using risk management process given in ISO 31000:2018.